Watch Ticker

Regeneron Pharmaceuticals Inc

Go to Regeneron Pharmaceuticals Inc Website

$562.99

17.53 (3.21%)

Live

Previous Close

$558.87

Day Range

$542.89 - $583.28

Previous Day Range

$541.6125 - $558.13

Market Cap

$59.2 billion USD

Day Vol.

1.7 million

Previous Day Vol.

1.4 million

Currency

USD

Primary Exchange

Nasdaq

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet ag...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Jesterai - Regeneron (REGN) Q2 EPS Jumps 53%

Regeneron reported strong Q2 2025 earnings, with Non-GAAP EPS of $12.89, surpassing estimates. The company saw growth in immunology and oncology segments, but faced challenges in ophthalmology due to market share losses and regulatory issues.

Related tickers: REGN, SNY, BAYRY.

Read Full Article

Vandana Singh - Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines

Regeneron reported Q2 earnings with revenue of $3.68 billion, up 4% year-over-year. Despite Eylea sales decline, the company saw growth in Sanofi antibody profits, particularly from Dupixent. However, potential regulatory delays for EYLEA HD applications were noted due to FDA inspection issues.

Related tickers: REGN, SNY, NVO.

Read Full Article

Trending Tickers

Please sign in to view